Our in vivo findings reinforce the tumor-suppressive function of miR-96-5p in PDAC by promoting antitumor immunity, as evidenced by M1 macrophage polarization and activation of antitumor effector CD8+ T cells within the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.